State Street Corp Aditxt, Inc. Transaction History

State Street Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.13 - $0.46 $7,735 - $27,370	59,500 Added 233.61%	84,970 $12,000
Q1 2022 May 16, 2022	BUY	$0.34 - $0.58 $830 - $1,416	2,442 Added 10.6%	25,470 $12,000
Q3 2021 Nov 15, 2021	BUY	$1.54 - $3.04 $13,552 - $26,752	8,800 Added 61.85%	23,028 $39,000
Q2 2021 Aug 16, 2021	BUY	$2.2 - $3.2 $31,301 - $45,529	14,228 New	14,228 $37,000

Ticker ADTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,161,130
Market Cap $749K
Description
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immuno...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.